Prehypertension and Pre-dysglycemia/dyslipidemia
Conditions
Interventions
Control Group:Distribute Health Education Manuals
Provide in-person guidance to subjects in setting health promotion goals and motivate them to achieve these goals
Wear smart watches to conduct health data monitoring.
Intervention Group:On the basis of the control group intervention, comprehensive intervention is carried out using a personalized Traditional Chinese Medicine (TCM) "Preventive Treatment" service pack
Sponsors
Chengdu University of Traditional Chinese Medicine Affiliated Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Overall Level: Inclusion Criteria 1. The research site must be able to enroll at least 50 eligible participants for each of the following conditions: critical hypertension, pre-diabetes, and borderline elevated blood lipids. 2. Participants must agree to participate in the project for a minimum of 2 years. 3. The research site must agree to designate at least 3 full-time or part-time project leaders to execute the TCM "Preventive Treatment" health promotion plan, implementing interventions, conducting follow-ups, ensuring data quality control, and fulfilling other research responsibilities. 4. The research center must agree to be randomly assigned to any group within the study. Individual level: 1.Individuals aged between 30 and 60 years old, who meet the diagnostic criteria for pre-hypertension and the TCM constitution assessment criteria for Yin-deficiency or Qi-stagnation constitution. 2.Or individuals aged between 18 and 65 years old, who meet the diagnostic criteria for pre-diabetes and the TCM constitution assessment criteria for phlegm-dampness or dampness-heat constitution. 3.Or individuals aged between 18 and 65 years old, who meet the diagnostic criteria for borderline elevated blood lipid and the TCM constitution assessment criteria for phlegm-dampness or dampness-heat constitution. 4.Willingly sign the informed consent form. 5. Agree to the long-term follow-up plan and actively cooperate with the research. 6. Have no plans to relocate or be away for extended periods in the near future.
Exclusion criteria
Exclusion criteria: 1. Individuals with a previous diagnosis of hypertension, diabetes, or hyperlipidemia. 2. Individuals who have been continuously taking antihypertensive, hypoglycemic, or lipid - regulating drugs (including drugs that affect blood pressure or glucose and lipid metabolism) within one month before enrollment. 3. Individuals who have experienced acute cardiovascular or cerebrovascular events within the past 6 months, or those with hepatic or renal insufficiency. 5. Women who are pregnant, planning to become pregnant, or are lactating during the study period. 6. Individuals with severe psychiatric disorders or cognitive dysfunction. 7. Individuals currently participating in other clinical trials. 8. Other conditions deemed by the investigator as unsuitable for participation in this clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease progression rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| The numerical changes in blood pressure, blood glucose, and blood lipid levels;TCM constitution score;TCM Syndrome Score;BMI;BMR;Scores of SF-12, PSQI, PHQ-9, and GAD-7; | — |
Countries
China
Contacts
Public ContactWenbin Wu
Chengdu University of Traditional Chinese Medicine Affiliated Hospital
Outcome results
None listed